Literature DB >> 26790444

Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.

Guangli Yin1,2, Zhengrui Xiao1,2, Ying Ni1,2, Xiaoyan Qu1,2, Hanxin Wu1,2, Hua Lu1,2, Sixuan Qian1,2, Lijuan Chen1,2, Jianyong Li1,2, Hairong Qiu3,4, Kourong Miao5,6.   

Abstract

Multidrug resistance 1 (MDR1) gene encodes P-glycoprotein (P-gp), which acts as an efflux pump and provides cell protection against various substances, and its single-nucleotide polymorphisms (SNPs) are associated with the development of malignant hematologic diseases. The present study aimed at investigating whether the MDR1 SNPs and haplotype variants were correlated with the susceptibility to multiple myeloma (MM). A total of 115 MM patients and 153 healthy controls from Jiangsu Han population were enrolled and genotyped by polymerase chain reaction-allele-specific primer (PCR-ASP) method or DNA direct sequencing at MDR1 loci of C1236T, G2677T/A, and C3435T. No significance was found in the distribution of alleles and genotypes in MDR1 three loci. Diplotype analysis has also demonstrated no effect in susceptibility to MM. But, in haplotype analysis, the haplotype of T-G-T was significantly more common than healthy controls (12.6 % in MM group vs. 1.7 % in control group, odds ratios (ORs) = 8.7, 95 % confidence interval (CI) 3.3-22.8, Pc  < 0.01). Our results pointed out that comparable allele, genotype, and diplotype frequencies among MM patients and controls in Chinese Jiangsu Han population were found; the frequency of T-G-T haplotype was significantly increased in MM group compared with the control group, which indicated that this haplotype might be associated with the susceptibility to MM.

Entities:  

Keywords:  Multidrug resistance 1 (MDR1); Multiple myeloma (MM); Single-nucleotide polymorphism (SNP)

Mesh:

Substances:

Year:  2016        PMID: 26790444     DOI: 10.1007/s13277-015-4574-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  MDR1 diplotypes as prognostic markers in multiple myeloma.

Authors:  Valentina Maggini; Gabriele Buda; Alessandro Martino; Silvano Presciuttini; Sara Galimberti; Enrico Orciuolo; Roberto Barale; Mario Petrini; Anna Maria Rossi
Journal:  Pharmacogenet Genomics       Date:  2008-05       Impact factor: 2.089

3.  The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China.

Authors:  Hairong Qiu; Huajie Dong; Shiyang Pan; Kourong Miao
Journal:  Biomed Pharmacother       Date:  2012-04-03       Impact factor: 6.529

4.  Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.

Authors:  Hua-Jie Dong; Kou-Rong Miao; Chun Qiao; Yun Zhuang; Wen-Yi Shen; Ming Hong; Lei Fan; Peng Liu; Wei Xu; Jian-Yong Li
Journal:  Leuk Lymphoma       Date:  2011-04-04

5.  Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysis.

Authors:  Limin Ma; Hongchao Liu; Linhai Ruan; Xuewen Yang; Haiping Yang; Yanming Feng
Journal:  Biomed Rep       Date:  2014-11-14

6.  Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.

Authors:  Jacob Vine; Sara Bar Cohen; Rosa Ruchlemer; Neta Goldschmidt; Moshe Levin; Diana Libster; Alexander Gural; Moshe E Gatt; David Lavie; Dina Ben-Yehuda; Deborah Rund
Journal:  Leuk Lymphoma       Date:  2014-03-19

7.  Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children.

Authors:  Carolina P Bellusci; Carlos Rocco; Paula Aulicino; Debora Mecikovsky; Verónica Curras; Soledad Hegoburu; Guillermo F Bramuglia; Rosa Bologna; Luisa Sen; Andrea Mangano
Journal:  Gene       Date:  2013-03-23       Impact factor: 3.688

8.  Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia.

Authors:  Kassogue Yaya; Dehbi Hind; Quachouh Meryem; Quessar Asma; Benchekroun Said; Nadifi Sellama
Journal:  Tumour Biol       Date:  2014-08-05

Review 9.  Genomics and the mechanism of P-glycoprotein (ABCB1).

Authors:  Zuben E Sauna; In-Wha Kim; Suresh V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

10.  Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

Authors:  Nizar M Mhaidat; Osama Y Alshogran; Omar F Khabour; Karem H Alzoubi; Ismail I Matalka; William J Haddadin; Ibraheem O Mahasneh; Ahmad N Aldaher
Journal:  J Exp Clin Cancer Res       Date:  2011-07-16
View more
  5 in total

1.  Genetic polymorphisms and multiple myeloma risk: a meta-analysis.

Authors:  Pengcheng Zhang; Bing Liu
Journal:  Ann Hematol       Date:  2020-03-11       Impact factor: 3.673

2.  The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.

Authors:  Jia Su; Qinglin Yu; Hao Zhu; Xiaojing Li; Hanbin Cui; Weiping Du; Lindan Ji; Maoqing Tong; Yibo Zheng; Hongyu Xu; Jianjiang Zhang; Yunyun Zhu; Yezi Xia; Ting Liu; Qi Yao; Jun Yang; Xiaomin Chen; Jingbo Yu
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

3.  Haplotype Analysis of MDR1 and Risk for Cervical Cancer in Northeastern Thailand

Authors:  Sophida Phuthong; Wannapa Settheetham-Ishida; Sitakan Natphopsuk; Dariwan Settheetham; Takafumi Ishida
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

4.  Association of MDR1 C1236T Polymorphisms and B Cell Non-Hodgkin Lymphoma.

Authors:  Wei Zhang; Qun Zhang; Hui Liang; SuLi Wang; Jing Pan; ShaoYing Pan; Bin Zhu; ZhiYong Ding; WenLi Zhao; Ying Ni
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

5.  Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.

Authors:  Manav Gandhi; Viral Bakhai; Jash Trivedi; Adarsh Mishra; Fernando De Andrés; Adrián LLerena; Rohit Sharma; Sujit Nair
Journal:  Transl Oncol       Date:  2022-09-11       Impact factor: 4.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.